Top Medical News

Cognetivity’s Integrated Cognitive Assessment Device Completes US FDA Registration

December 01, 2021

By Abby Reinhard

After being granted FDA clearance, the medical device is approved for commercial distribution in the US for cognitive assessments in dementia studies.

FDA Accepts sNDA, Grants Priority Review to Fenfluramine for Lennox-Gastaut Syndrome

December 01, 2021

By Marco Meglio

After demonstrating a significant effect in reducing the frequency of drop seizures, fenfluramine aims to build on its previous indication in rare epileptic disorders, as it is currently approved to treat Dravet syndrome.

NeuroVoices: Jeffrey Cummings, MD, ScD, on Evaluating Alzheimer Trial Funding, Eliminating Wasteful Costs

December 01, 2021

By Marco Meglio

The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas discussed his recently published research on the costs of developing treatments for Alzheimer disease.

Lecanemab Reduces Amyloid in Patients With Early Alzheimer Disease

November 30, 2021

By Abby Reinhard

Data show a clinical benefit via a reduction in brain amyloid as early as 3 months in the open-label extension period.

Insomnia Treatment May Prevent Depression in Older Adults

November 30, 2021

By Abby Reinhard

CBT-I treatment was found to provide an overall benefit in preventing incident and recurrent major depression in the patient population, highlighting the need for community-level screening for insomnia.

Featured


Latest Videos


Most Recent